Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Solid Biosciences (SLDB) Interest & Investment Income (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Interest & Investment Income for 8 consecutive years, with $1.9 million as the latest value for Q4 2024.

  • Quarterly Interest & Investment Income rose 9.38% to $1.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Dec 2024, up 24.9% year-over-year, with the annual reading at $9.9 million for FY2025, 4.59% up from the prior year.
  • Interest & Investment Income hit $1.9 million in Q4 2024 for Solid Biosciences, down from $2.3 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.7 million in Q1 2024 to a low of -$20000.0 in Q3 2020.
  • Historically, Interest & Investment Income has averaged $1.1 million across 5 years, with a median of $1.1 million in 2022.
  • Biggest five-year swings in Interest & Investment Income: plummeted 108.54% in 2021 and later soared 3231.48% in 2023.
  • Year by year, Interest & Investment Income stood at -$16000.0 in 2020, then rose by 18.75% to -$13000.0 in 2021, then soared by 11900.0% to $1.5 million in 2022, then rose by 14.73% to $1.8 million in 2023, then increased by 9.38% to $1.9 million in 2024.
  • Business Quant data shows Interest & Investment Income for SLDB at $1.9 million in Q4 2024, $2.3 million in Q3 2024, and $2.6 million in Q2 2024.